The flowchart above depicts the preclinical testing screening strategy. Only models that have been phenotypically validated to demonstrate LOAD-like endophenotypes (see Disease Modeling Project) will enter the primary screen. Each phase has a predetermined Go/No Go criteria that must be met before moving to the next phase.